161 related articles for article (PubMed ID: 38182569)
1. Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma.
Chen J; Huang Q; Li YQ; Li Z; Zheng J; Hu W; Yang Y; Wu D; Bei JX; Gu B; Wang J; Li Y
Cell Death Dis; 2024 Jan; 15(1):15. PubMed ID: 38182569
[TBL] [Abstract][Full Text] [Related]
2. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction.
Sugihara H; Ishimoto T; Yasuda T; Izumi D; Eto K; Sawayama H; Miyake K; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Baba H
Med Oncol; 2015 Jun; 32(6):618. PubMed ID: 25920609
[TBL] [Abstract][Full Text] [Related]
4. Integrative proteomic characterization of adenocarcinoma of esophagogastric junction.
Li S; Yuan L; Xu ZY; Xu JL; Chen GP; Guan X; Pan GZ; Hu C; Dong J; Du YA; Yang LT; Ni MW; Jiang RB; Zhu X; Lv H; Xu HD; Zhang SJ; Qin JJ; Cheng XD
Nat Commun; 2023 Feb; 14(1):778. PubMed ID: 36774361
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma.
Wang Y; Sun H; Zhu N; Wu X; Sui Z; Gong L; Yu Z
Front Oncol; 2021; 11():640080. PubMed ID: 33854974
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
9. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of preoperative indocyanine green fluorescence marking in laparoscopic gastrectomy for proximal gastric and esophagogastric junction adenocarcinoma (ICG MAP study).
Omori T; Hara H; Shinno N; Yamamoto M; Kanemura T; Takeoka T; Akita H; Wada H; Yasui M; Matsuda C; Nishimura J; Ohue M; Sakon M; Miyata H
Langenbecks Arch Surg; 2022 Dec; 407(8):3387-3396. PubMed ID: 36227384
[TBL] [Abstract][Full Text] [Related]
11. HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma.
Wang ZY; Xiao W; Jiang YZ; Dong W; Zhang XW; Zhang L
Thorac Cancer; 2021 Mar; 12(5):650-658. PubMed ID: 33471419
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
13. [Laparoscopic proximal gastrectomy and lymph node resection in adenocarcinoma of the esophagogastric junction].
Zhao JJ; Liu FL
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):114-119. PubMed ID: 35176821
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
Chen L; Tang K; Wang S; Chen D; Ding K
Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
[TBL] [Abstract][Full Text] [Related]
15. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
[TBL] [Abstract][Full Text] [Related]
16. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.
Wang R; Song S; Qin J; Yoshimura K; Peng F; Chu Y; Li Y; Fan Y; Jin J; Dang M; Dai E; Pei G; Han G; Hao D; Li Y; Chatterjee D; Harada K; Pizzi MP; Scott AW; Tatlonghari G; Yan X; Xu Z; Hu C; Mo S; Shanbhag N; Lu Y; Sewastjanow-Silva M; Fouad Abdelhakeem AA; Peng G; Hanash SM; Calin GA; Yee C; Mazur P; Marsden AN; Futreal A; Wang Z; Cheng X; Ajani JA; Wang L
Cancer Cell; 2023 Aug; 41(8):1407-1426.e9. PubMed ID: 37419119
[TBL] [Abstract][Full Text] [Related]
17. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
Stein HJ; von Rahden BH; Höfler H; Siewert JR
Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
[TBL] [Abstract][Full Text] [Related]
19. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification.
Chung JW; Lee GH; Choi KS; Kim DH; Jung KW; Song HJ; Choi KD; Jung HY; Kim JH; Yook JH; Kim BS; Jang SJ
Dis Esophagus; 2009; 22(8):676-81. PubMed ID: 19222529
[TBL] [Abstract][Full Text] [Related]
20. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
